Skip to content

4/AAccepted Mar 4, 9:01 PM ET

Lebwohl David 4/A

NTLAIntellia Therapeutics, Inc.

Accepted (ET)

9:01 PM

Mar 4, 2022

Filed

Mar 4, 2022

Documents

1

Size

5.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.